{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:12:27Z","timestamp":1773083547119,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"crossref","award":["SHDC22024317"],"award-info":[{"award-number":["SHDC22024317"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai's Three-Year Action Plan for Strengthening Public Health System Construction","award":["GWVI-9"],"award-info":[{"award-number":["GWVI-9"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["ZD2021CY001"],"award-info":[{"award-number":["ZD2021CY001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11540-y","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:02:31Z","timestamp":1758877351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of ten diagnostic models for metabolic dysfunction-associated fatty liver disease in lean people living with HIV"],"prefix":"10.1186","volume":"25","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinzhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"11540_CR1","unstructured":"UNAIDS, Global HIV, AIDS statistics. 2024.\u00a0https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed 1 Jan 2015."},{"issue":"22","key":"11540_CR2","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1097\/CM9.0000000000003383","volume":"137","author":"Acquired Immunodeficiency Syndrome Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention","year":"2024","unstructured":"Acquired Immunodeficiency Syndrome Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention. Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection\/acquired immunodeficiency syndrome (2024 edition). Chin Med J (Engl). 2024;137(22):2654\u201380.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"11540_CR3","doi-asserted-by":"publisher","first-page":"ofae132","DOI":"10.1093\/ofid\/ofae132","volume":"11","author":"DK Nomah","year":"2024","unstructured":"Nomah DK, Jamarkattel S, Bruguera A, Moreno-Forn\u00e9s S, D\u00edaz Y, Alonso L, et al. Evolving AIDS- and non-AIDS mortality and predictors in the PISCIS cohort of people piving with HIV in Catalonia and the Balearic Islands (Spain), 1998\u20132020. Open Forum Infect Dis. 2024;11(4):ofae132.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"11540_CR4","first-page":"87","volume":"25","author":"J Navarro","year":"2022","unstructured":"Navarro J. HIV and liver disease. AIDS Rev. 2022;25(2):87\u201396.","journal-title":"AIDS Rev"},{"issue":"11","key":"11540_CR5","first-page":"955","volume":"12","author":"JG Fan","year":"2024","unstructured":"Fan JG, Xu XY, Yang RX, Nan YM, Wei L, Jia JD, et al. Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (Version 2024). J Clin Transl Hepatol. 2024;12(11):955\u201374.","journal-title":"J Clin Transl Hepatol"},{"issue":"7","key":"11540_CR6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. International consensus panel. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999\u2013e20141.","journal-title":"Gastroenterology"},{"issue":"7","key":"11540_CR7","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cgh.2023.01.001","volume":"21","author":"M Kalligeros","year":"2023","unstructured":"Kalligeros M, Vassilopoulos A, Shehadeh F, Vassilopoulos S, Lazaridou I, Mylonakis E, et al. Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21(7):1708\u201322.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"11540_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, et al. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: Co-sponsored by the American association for the study of liver diseases (AASLD). Endocr Pract. 2022;28(5):528\u201362.","journal-title":"Endocr Pract"},{"issue":"2","key":"11540_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","volume":"19","author":"M Eslam","year":"2025","unstructured":"Eslam M, Fan JG, Yu ML, Wong VW, Cua IH, Liu CJ, et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and managementof metabolic dysfunction-associated fatty liver disease. Hepatol Int. 2025;19(2):261\u2013301.","journal-title":"Hepatol Int"},{"issue":"7","key":"11540_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"key":"11540_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"11540_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137(3):865\u201372.","journal-title":"Gastroenterology"},{"issue":"1","key":"11540_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3350\/kjhep.2011.17.1.19","volume":"17","author":"YJ Park","year":"2011","unstructured":"Park YJ, Lim JH, Kwon ER, Kim HK, Jung MC, Seol KH, et al. Development and validation of a simple index system to predict nonalcoholic fatty liver disease. Korean J Hepatol. 2011;17(1):19\u201326.","journal-title":"Korean J Hepatol"},{"issue":"12","key":"11540_CR14","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1111\/jgh.12665","volume":"29","author":"M Otgonsuren","year":"2014","unstructured":"Otgonsuren M, Estep MJ, Hossain N, Younossi E, Frost S, Henry L, et al. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). J Gastroenterol Hepatol. 2014;29(12):2006\u201313.","journal-title":"J Gastroenterol Hepatol"},{"key":"11540_CR15","doi-asserted-by":"publisher","first-page":"16494","DOI":"10.1038\/srep16494","volume":"5","author":"J Wang","year":"2015","unstructured":"Wang J, Xu C, Xun Y, Lu Z, Shi J, Yu C, et al. ZJU index: A novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015;5:16494.","journal-title":"Sci Rep"},{"issue":"10","key":"11540_CR16","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00592-017-1024-8","volume":"54","author":"L Li","year":"2017","unstructured":"Li L, You W, Ren W. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population. Acta Diabetol. 2017;54(10):905\u201311.","journal-title":"Acta Diabetol"},{"key":"11540_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cca.2017.09.020","volume":"475","author":"YJ Zhou","year":"2017","unstructured":"Zhou YJ, Zhou YF, Zheng JN, Liu WY, Van Poucke S, Zou TT, et al. NAFL screening score: A basic score identifying ultrasound-diagnosed non-alcoholic fatty liver. Clin Chim Acta. 2017;475:44\u201350.","journal-title":"Clin Chim Acta"},{"issue":"21","key":"11540_CR18","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.21037\/atm-20-2951","volume":"8","author":"S Jeong","year":"2020","unstructured":"Jeong S, Kim K, Chang J, Choi S, Kim SM, Son JS, et al. Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance. Ann Transl Med. 2020;8(21):1414.","journal-title":"Ann Transl Med"},{"issue":"1","key":"11540_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1089\/met.2020.0054","volume":"19","author":"M Vural Keskinler","year":"2021","unstructured":"Vural Keskinler M, Mutlu HH, Sirin A, Erkalma Senates B, Colak Y, et al. Visceral adiposity index as a practical tool in patients with biopsy-proven nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Metab Syndr Relat Disord. 2021;19(1):26\u201331.","journal-title":"Metab Syndr Relat Disord"},{"key":"11540_CR20","doi-asserted-by":"publisher","first-page":"6678755","DOI":"10.1155\/2021\/6678755","volume":"2021","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li B, Liu N, Wang P, He J. Evaluation of different anthropometric indicators for screening for nonalcoholic fatty liver disease in elderly individuals. Int J Endocrinol. 2021;2021:6678755.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"11540_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12916-025-03914-5","volume":"23","author":"LE van Eekeren","year":"2025","unstructured":"van Eekeren LE, Vadaq N, Blaauw MJT, Groenendijk AL, Vos WAJW, Nelwan EJ, et al. Distinct metabolic perturbations link liver steatosis and incident CVD in lean but not obese PWH. BMC Med. 2025;23(1):78.","journal-title":"BMC Med"},{"issue":"3","key":"11540_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"11","key":"11540_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/hiv.13542","volume":"24","author":"J Ambrosioni","year":"2023","unstructured":"Ambrosioni J, Levi L, Alagaratnam J, Van Bremen K, Mastrangelo A, Waalewijn H, et al. Major revision version 12.0 of the European AIDS clinical society guidelines 2023. HIV Med. 2023;24(11):1126\u201336.","journal-title":"HIV Med"},{"issue":"10","key":"11540_CR24","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1093\/cid\/ciaa430","volume":"71","author":"A Cervo","year":"2020","unstructured":"Cervo A, Milic J, Mazzola G, Schepis F, Petta S, Krahn T, et al. Prevalence, predictors, and severity of lean nonalcoholic fatty liver disease in patients living with human immunodeficiency virus. Clin Infect Dis. 2020;71(10):e694\u2013701.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11540_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep4.1124","volume":"2","author":"H Hagstr\u00f6m","year":"2017","unstructured":"Hagstr\u00f6m H, Nasr P, Ekstedt M, Hammar U, St\u00e5l P, Hultcrantz R, et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study. Hepatol Commun. 2017;2(1):48\u201357.","journal-title":"Hepatol Commun"},{"issue":"Suppl 2","key":"11540_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hiv.12935","volume":"21","author":"A d\u2019Arminio Monforte","year":"2020","unstructured":"d\u2019Arminio Monforte A, Bonnet F, Bucher HC, Pourcher V, Pantazis N, Pelchen-Matthews A, et al. What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohorts. HIV Med. 2020;21(Suppl 2):3\u201316.","journal-title":"HIV Med"},{"issue":"1","key":"11540_CR27","first-page":"e000166","volume":"4","author":"MB Kaspar","year":"2017","unstructured":"Kaspar MB, Sterling RK. Mechanisms of liver disease in patients infected with HIV. BMJOpen Gastroenterol. 2017;4(1):e000166.","journal-title":"BMJOpen Gastroenterol"},{"issue":"7","key":"11540_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/CM9.0000000000003141","volume":"138","author":"M Hou","year":"2025","unstructured":"Hou M, Gu Q, Cui J, Dou Y, Huang X, Li J, et al. Proportion and clinical characteristics of metabolic-associated fatty liver disease and associated liver fibrosis in an urban Chinese population. Chin Med J (Engl). 2025;138(7):829\u201337.","journal-title":"Chin Med J (Engl)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11540-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:02:33Z","timestamp":1758877353000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11540-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11540"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11540-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients. This study was performed in accordance with the Declaration of Helsinki. The ethics committee of Shanghai Public Health Clinical Center approved the study protocol, including any relevant details. This study was registered at ClinicalTrials.gov under the number NCT04215926 on December 29, 2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1147"}}